Regulation of Myc transcription by an enhancer cluster dedicated to pluripotency and early embryonic expression.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
10 May 2024
Historique:
received: 12 11 2022
accepted: 23 04 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 10 5 2024
Statut: epublish

Résumé

MYC plays various roles in pluripotent stem cells, including the promotion of somatic cell reprogramming to pluripotency, the regulation of cell competition and the control of embryonic diapause. However, how Myc expression is regulated in this context remains unknown. The Myc gene lies within a ~ 3-megabase gene desert with multiple cis-regulatory elements. Here we use genomic rearrangements, transgenesis and targeted mutation to analyse Myc regulation in early mouse embryos and pluripotent stem cells. We identify a topologically-associated region that homes enhancers dedicated to Myc transcriptional regulation in stem cells of the pre-implantation and early post-implantation embryo. Within this region, we identify elements exclusively dedicated to Myc regulation in pluripotent cells, with distinct enhancers that sequentially activate during naive and formative pluripotency. Deletion of pluripotency-specific enhancers dampens embryonic stem cell competitive ability. These results identify a topologically defined enhancer cluster dedicated to early embryonic expression and uncover a modular mechanism for the regulation of Myc expression in different states of pluripotency.

Identifiants

pubmed: 38729993
doi: 10.1038/s41467-024-48258-5
pii: 10.1038/s41467-024-48258-5
doi:

Substances chimiques

Proto-Oncogene Proteins c-myc 0
Myc protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3931

Subventions

Organisme : Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación)
ID : PGC2018-096486-B-I00
Organisme : Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación)
ID : CEX2020-001041-S
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : SC1-BHC-07-2019
Organisme : Comunidad de Madrid
ID : P2022/BMD-7245 CARDIOBOOST-CM

Informations de copyright

© 2024. The Author(s).

Références

Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
doi: 10.1016/j.cell.2006.07.024 pubmed: 16904174
Nichols, J. & Smith, A. Naive and primed pluripotent states. Cell Stem Cell https://doi.org/10.1016/j.stem.2009.05.015 (2009).
Hackett, J. A. & Azim Surani, M. Regulatory principles of pluripotency: from the ground state up. Cell Stem Cell https://doi.org/10.1016/j.stem.2014.09.015 (2014).
Sperber, H. et al. The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nat. Cell Biol. https://doi.org/10.1038/ncb3264 (2015).
Kinoshita, M. et al. Capture of mouse and human stem cells with features of formative pluripotency. Cell Stem Cell 28, 453–471.e8 (2021).
doi: 10.1016/j.stem.2020.11.005 pubmed: 33271069 pmcid: 7939546
Kalkan, T. et al. Tracking the embryonic stem cell transition from ground state pluripotency. Development https://doi.org/10.1242/dev.142711 (2017).
Hayashi, K., Ohta, H., Kurimoto, K., Aramaki, S. & Saitou, M. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 146, 519–532 (2011).
doi: 10.1016/j.cell.2011.06.052 pubmed: 21820164
Clavería, C., Giovinazzo, G., Sierra, R. & Torres, M. Myc-driven endogenous cell competition in the early mammalian embryo. Nature 500, 39–44 (2013).
doi: 10.1038/nature12389 pubmed: 23842495
Sancho, M. et al. Competitive interactions eliminate unfit embryonic stem cells at the onset of differentiation. Dev. Cell 26, 19–30 (2013).
doi: 10.1016/j.devcel.2013.06.012 pubmed: 23867226 pmcid: 3714589
Díaz-Díaz, C. et al. Pluripotency surveillance by myc-driven competitive elimination of differentiating cells. Dev. Cell 42, 585–599.e4 (2017).
doi: 10.1016/j.devcel.2017.08.011 pubmed: 28919206
Hashimoto, M. & Sasaki, H. Epiblast formation by TEAD-YAP-dependent expression of pluripotency factors and competitive elimination of unspecified cells. Dev. Cell https://doi.org/10.1016/j.devcel.2019.05.024 (2019).
Baker, N. E. Emerging mechanisms of cell competition. Nat. Rev. Genet. https://doi.org/10.1038/s41576-020-0262-8 (2020).
Hashimoto, M. & Sasaki, H. Cell competition controls differentiation in mouse embryos and stem cells. Curr. Opin. Cell Biol https://doi.org/10.1016/j.ceb.2020.07.001 (2020).
Scognamiglio, R. et al. Myc depletion induces a pluripotent dormant state mimicking diapause. Cell https://doi.org/10.1016/j.cell.2015.12.033 (2016).
Sotelo, J. et al. Long-range enhancers on 8q24 regulate c-Myc. Proc. Natl. Acad. Sci. USA https://doi.org/10.1073/pnas.0906067107 (2010).
Uslu, V. V. et al. Long-range enhancers regulating Myc expression are required for normal facial morphogenesis. Nat. Genet. 46, 1–24 (2014).
doi: 10.1038/ng.2971
Zhang, X. et al. Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers. Nat. Genet. 48, 176–182 (2016).
doi: 10.1038/ng.3470 pubmed: 26656844
Bahr, C. et al. A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies. Nature 553, 515–520 (2018).
doi: 10.1038/nature25193 pubmed: 29342133
Tseng, Y. Y. et al. PVT1 dependence in cancer with MYC copy-number increase. Nature https://doi.org/10.1038/nature13311 (2014).
Cho, S. W. et al. Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element. Cell https://doi.org/10.1016/j.cell.2018.03.068 (2018).
Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307–319 (2013).
doi: 10.1016/j.cell.2013.03.035 pubmed: 23582322 pmcid: 3653129
Buecker, C. et al. Reorganization of enhancer patterns in transition from naive to primed pluripotency. Cell Stem Cell https://doi.org/10.1016/j.stem.2014.04.003 (2014).
Factor, D. C. et al. Epigenomic comparison reveals activation of ‘seed’ enhancers during transition from naive to primed pluripotency. Cell Stem Cell https://doi.org/10.1016/j.stem.2014.05.005 (2014).
Kurimoto, K. et al. Quantitative dynamics of chromatin remodeling during germ cell specification from mouse embryonic stem cells. Cell Stem Cell https://doi.org/10.1016/j.stem.2015.03.002 (2015).
Zylicz, J. J. et al. Chromatin dynamics and the role of G9a in gene regulation and enhancer silencing during early mouse development. Elife https://doi.org/10.7554/eLife.09571 (2015).
Respuela, P. et al. Foxd3 promotes exit from naive pluripotency through enhancer decommissioning and inhibits germline specification. Cell Stem Cell https://doi.org/10.1016/j.stem.2015.09.010 (2016).
Shirane, K. et al. Global landscape and regulatory principles of DNA methylation reprogramming for germ cell specification by mouse pluripotent stem cells. Dev. Cell https://doi.org/10.1016/j.devcel.2016.08.008 (2016).
Bonev, B. et al. Multiscale 3D genome rewiring during mouse article multiscale 3D genome rewiring during mouse neural development. Cell https://doi.org/10.1016/j.cell.2017.09.043 (2017).
Dixon, J. R. et al. Integrative detection and analysis of structural variation in cancer genomes. Nat. Genet. https://doi.org/10.1038/s41588-018-0195-8 (2018).
Hann, S. R. & Eisenman, R. N. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell Biol. https://doi.org/10.1128/mcb.4.11.2486-2497.1984 (1984).
Liu, J. & Levens, D. Making Myc. Curr. Top. Microbiol. Immunol. 302, 1–32 (2006).
pubmed: 16620023
Levens, D. Cellular MYCro economics: balancing MYC function with MYC expression. Cold Spring Harb. Perspect. Med. https://doi.org/10.1101/cshperspect.a014233 (2013).
Huang, C. Y., Bredemeyer, A. L., Walker, L. M., Bassing, C. H. & Sleckman, B. P. Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse. Eur. J. Immunol. https://doi.org/10.1002/eji.200737972 (2008).
Fernández-de-Manúel, L., Díaz-Díaz, C., Jiménez-Carretero, D., Torres, M. & Montoya, M. C. ESC-track: a computer workflow for 4-D segmentation, tracking, lineage tracing and dynamic context analysis of ESCs. Biotechniques 62, 215–222 (2017).
doi: 10.2144/000114545 pubmed: 28528574
Copeland, N. G., Jenkins, N. A. & Court, D. L. Recombineering: a powerful new tool for mouse functional genomics. Nat. Rev. Genet. 2, 769–779 (2001).
doi: 10.1038/35093556 pubmed: 11584293
Mastromina, I., Verrier, L., Silva, J. C., Storey, K. G. & Dale, J. K. Myc activity is required for maintenance of the neuromesodermal progenitor signalling network and for segmentation clock gene oscillations in mouse. Development 145, dev161091 (2018).
doi: 10.1242/dev.161091 pubmed: 30061166 pmcid: 6078331
Dequéant, M. L. et al. A complex oscillating network of signaling genes underlies the mouse segmentation clock. Science https://doi.org/10.1126/science.1133141 (2006).
Fongang, B. & Kudlicki, A. The precise timeline of transcriptional regulation reveals causation in mouse somitogenesis network. BMC Dev. Biol. https://doi.org/10.1186/1471-213X-13-42 (2013).
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. & Brivanlou, A. H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. https://doi.org/10.1038/nm979 (2004).
Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature https://doi.org/10.1038/nature06968 (2008).
Oki, S. et al. ChIP‐Atlas: a data‐mining suite powered by full integration of public ChIP‐seq data. EMBO Rep. https://doi.org/10.15252/embr.201846255 (2018).
Zou, Z., Ohta, T., Miura, F. & Oki, S. ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data. Nucleic Acids Res. https://doi.org/10.1093/nar/gkac199 (2022).
Fang, R. et al. Mapping of long-range chromatin interactions by proximity ligation-assisted ChIP-seq. Cell Res. 26, 1345–1348 (2016).
doi: 10.1038/cr.2016.137 pubmed: 27886167 pmcid: 5143423
Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell https://doi.org/10.1016/S0092-8674(00)81769-9 (1998).
Avilion, A. A. et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. https://doi.org/10.1101/gad.224503 (2003).
Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell https://doi.org/10.1016/S0092-8674(03)00392-1 (2003).
Mitsui, K. et al. The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell https://doi.org/10.1016/S0092-8674(03)00393-3 (2003).
Orkin, S. H. Chipping away at the embryonic stem cell network. Cell https://doi.org/10.1016/j.cell.2005.09.002 (2005).
Wang, J. et al. A protein interaction network for pluripotency of embryonic stem cells. Nature https://doi.org/10.1038/nature05284 (2006).
Osorno, R. et al. The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression. Development https://doi.org/10.1242/dev.078071 (2012).
Tsume-Kajioka, M., Kimura-Yoshida, C., Mochida, K., Ueda, Y. & Matsuo, I. BET proteins are essential for the specification and maintenance of the epiblast lineage in mouse preimplantation embryos. BMC Biol. 20, 1–25 (2022).
doi: 10.1186/s12915-022-01251-0
Sone, M. et al. Hybrid cellular metabolism coordinated by Zic3 and Esrrb synergistically enhances induction of naive pluripotency. Cell Metab. 25, 1103–1117 (2017).
doi: 10.1016/j.cmet.2017.04.017 pubmed: 28467928
Guo, G. et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136, 1063–1069 (2009).
doi: 10.1242/dev.030957 pubmed: 19224983 pmcid: 2685927
Azami, T. et al. Klf5 suppresses ERK signaling in mouse pluripotent stem cells. PLoS ONE 13, 1–14 (2018).
doi: 10.1371/journal.pone.0207321
Yang, S. H. et al. ZIC3 controls the transition from naive to primed pluripotency. Cell Rep. 27, 3215–3227 (2019).
doi: 10.1016/j.celrep.2019.05.026 pubmed: 31189106 pmcid: 6581693
Van Den Boom, V. et al. UTF1 is a chromatin-associated protein involved in ES cell differentiation. J. Cell Biol. 178, 913–924 (2007).
doi: 10.1083/jcb.200702058 pubmed: 17785516 pmcid: 2064617
Raina, K., Dey, C., Thool, M., Sudhagar, S. & Thummer, R. P. An insight into the role of UTF1 in development, stem cells, and cancer. Stem Cell Rev. Rep. 17, 1280–1293 (2021).
doi: 10.1007/s12015-021-10127-9 pubmed: 33517544
Rauluseviciute, I. et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res https://doi.org/10.1093/nar/gkad1059 (2023).
Fernandez-Tresguerres, B. et al. Evolution of the mammalian embryonic pluripotency gene regulatory network. Proc. Natl. Acad. Sci. USA 107, 19955–19960 (2010).
doi: 10.1073/pnas.1010708107 pubmed: 21048080 pmcid: 2993340
Villar, D. et al. Enhancer evolution across 20 mammalian species. Cell 160, 554–566 (2015).
doi: 10.1016/j.cell.2015.01.006 pubmed: 25635462 pmcid: 4313353
Snetkova, V. et al. Ultraconserved enhancer function does not require perfect sequence conservation. Nat. Genet. https://doi.org/10.1038/s41588-021-00812-3 (2021).
Jin, K. et al. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis. Cell. Mol. Life Sci. 76, 4275–4289 (2019).
doi: 10.1007/s00018-019-03222-1 pubmed: 31309249 pmcid: 6803569
Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R. & Bradley, A. A null C-Myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671–682 (1993).
doi: 10.1101/gad.7.4.671 pubmed: 8458579
Alexandrova, S. et al. Selection and dynamics of embryonic stem cell integration into early mouse embryos. Development 143, 24–34 (2016).
pubmed: 26586221 pmcid: 4725202
Montavon, T. et al. A regulatory archipelago controls hox genes transcription in digits. Cell 147, 1132–1145 (2011).
doi: 10.1016/j.cell.2011.10.023 pubmed: 22118467
Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100–106 (2021).
doi: 10.1038/s41592-020-01018-x pubmed: 33318659
Legland, D., Arganda-Carreras, I. & Andrey, P. MorphoLibJ: integrated library and plugins for mathematical morphology with ImageJ. Bioinformatics 32, 3532–3534 (2016).
doi: 10.1093/bioinformatics/btw413 pubmed: 27412086
Wang, Y. et al. The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. Genome Biol. 19, 151 (2018).
doi: 10.1186/s13059-018-1519-9 pubmed: 30286773 pmcid: 6172833

Auteurs

Lin Li-Bao (L)

Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Centro Andaluz de Biología del Desarrollo (CABD), Sevilla, Spain.

Covadonga Díaz-Díaz (C)

Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Morena Raiola (M)

Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Rocío Sierra (R)

Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Susana Temiño (S)

Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Francisco J Moya (FJ)

Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.

Sandra Rodriguez-Perales (S)

Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.

Elisa Santos (E)

Pluripotent Cell Technology Unit, Centro Nacional de Investigaciones Cardiovasculares, CNIC, Madrid, Spain.

Giovanna Giovinazzo (G)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Pluripotent Cell Technology Unit, Centro Nacional de Investigaciones Cardiovasculares, CNIC, Madrid, Spain.

Tore Bleckwehl (T)

Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.

Álvaro Rada-Iglesias (Á)

Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC/University of Cantabria, Santander, Spain.

Francois Spitz (F)

Department of Human Genetics, The University of Chicago, Chicago, IL, USA.
Developmental Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.

Miguel Torres (M)

Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. mtorres@cnic.es.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. mtorres@cnic.es.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH